Anti-viral treatment with pertussis toxin b oligomer

Details Anti-viral treatment with pertussis toxin b oligomer Anti-viral treatment with pertussis toxin b oligomer

A - Human Necessities

61

K

A61K 39/00 (2006.01) A61K 38/16 (2006.01) A61K 39/10 (2006.01) A61K 39/12 (2006.01) A61K 39/21 (2006.01) A61K 39/295 (2006.01) A61K 39/38 (2006.01) A61K 39/39 (2006.01) A61K 45/00 (2006.01)

Patent

CA 2300431

There is disclosed a method for anti-viral therapy treatment with the Pertussis toxin B-oligomer, wherein the B-oligomer is composed of from two to ten subunits of PTX B-oligomer selected from the group consisting of S2, S3, S4, S5, and combinations thereof.

L'invention concerne un procédé de traitement thérapeutique antiviral utilisant le B-oligomère de la toxine coquelucheuse (PTX), cet oligomère étant composé de deux à dix sous-unités de PTX choisies parmi le groupe renfermant S2, S3, S4, S5 et des combinaisons de ces sous-unités.

Affiliated with

Also associated with

Rating

Anti-viral treatment with pertussis toxin b oligomer does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Anti-viral treatment with pertussis toxin b oligomer, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-viral treatment with pertussis toxin b oligomer will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-2091630